Buy MK-677 (Ibutamoren) 10mg — 50 Tablets of the Only Orally Active Growth Hormone Secretagogue That Works From Day One

In a landmark double-blind clinical trial, adults aged 60–81 taking 25mg of MK-677 daily for 12 months saw their 24-hour mean GH and IGF-1 levels elevated to those of healthy young adults — alongside a +1.1 kg increase in fat-free mass versus placebo. In a separate clinical study on hip fracture recovery, ibutamoren subjects demonstrated significant improvements in stair climbing power and gait speed, and a tendency towards more independent living — particularly in 70% of pre-fracture-independent patients (p=0.036). This is a compound with human clinical trials behind it. Multiple of them.

There’s a specific frustration that every serious athlete, biohacker, and longevity-minded person eventually hits: the desire for growth hormone’s benefits — deeper sleep, better recovery, lean muscle preservation, improved body composition — without the cost, complexity, and injection burden of synthetic HGH. MK-677 (Ibutamoren) 10mg is the compound that solves that problem. It’s oral, once-daily, non-suppressive, and backed by more human clinical research than virtually any other compound in the GH-axis enhancement category.

Originally developed by Merck & Co., MK-677 has been studied across indications including sarcopenia, muscle wasting, osteoporosis, hip fracture recovery, GH deficiency, and Alzheimer’s disease — building one of the most comprehensive published research bases of any research chemical on the market. Users across the USA, Canada, Germany, France, the UK, and Australia have adopted it as the most practical, most studied, and most complete oral GH optimization compound available.

The global growth hormone and GH secretagogue research market continues to expand significantly as part of the broader $17.75 billion performance and metabolic health enhancement market projected to exceed $46 billion by 2035. Within that space, MK-677 stands apart as the only non-peptide, orally bioavailable ghrelin receptor agonist with Phase II human clinical data across multiple therapeutic indications — and a 10mg tablet format that gives you precision, flexibility, and full protocol control.

---

What Is MK-677 (Ibutamoren) — And What Makes It Genuinely Different?

MK-677, also known as Ibutamoren and by the developmental designations MK-0677 and L-163,191, is a non-peptide, orally bioavailable agonist of the growth hormone secretagogue receptor (GHS-R1a). It was originally developed by Merck & Co. and has been studied extensively in published preclinical and clinical pharmacology research for its activation of the ghrelin receptor and downstream modulation of the growth hormone / IGF-1 axis.

MK-677 is a spiropiperidine small molecule — not a peptide — that mimics ghrelin by binding to the GHS-R1a receptor. Unlike injectable GHRPs such as Ipamorelin or GHRP-6, MK-677 is orally active: a single daily tablet produces consistent, measurable GH and IGF-1 elevation without any injection required. Its 24-hour half-life makes once-daily dosing ideal for sustained hormonal optimization.

This is the fundamental distinction that makes MK-677 (Ibutamoren) for sale unlike anything else in the GH optimization space. Injectable GH peptides require multiple daily injections, refrigerated storage, reconstitution, and precise timing. MK-677 requires one tablet. That’s it.

And critically: MK-677 does not interact with androgen receptors — it is not a SARM in the traditional sense. It acts on the GHS-R1a ghrelin receptor pathway exclusively, which is why it produces no testosterone suppression, requires no PCT when used alone, and can be stacked freely alongside SARMs without compounding their suppressive effects.

---

MK-677 (Ibutamoren) 10mg — Full Technical Specification

---

How Does MK-677 (Ibutamoren) Work? The Ghrelin Axis Explained

Think of ghrelin as a green light for growth hormone release. By activating the ghrelin receptor (GHS-R1a), MK-677 stimulates the pituitary gland to increase pulsatile GH secretion — which raises IGF-1 levels downstream. In a double-blind randomized study of adults aged 60–81 taking 25mg/day, MK-677 increased 24-hour mean GH and IGF-1 toward young-adult levels.

Unlike injectable peptides such as CJC-1295 or Ipamorelin — which stimulate GH through the GHRH receptor pathway — MK-677 mimics ghrelin at the GHS-R1a receptor. This is a distinct and complementary mechanism. The result is pulsatile GH release that closely mirrors the body’s natural rhythm, driving IGF-1 elevation that is sustained across the full 24-hour dosing window due to MK-677’s long half-life.

The entire cascade from one daily tablet:

Tablet → GHS-R1a Activation → Pituitary GH Release → Liver IGF-1 Production → Downstream anabolic, regenerative, and metabolic effects

IGF-1 levels increase in a dose-dependent manner with MK-677 — higher doses produce higher IGF-1 levels, contributing to more pronounced muscle-building and recovery effects. Clinical research has confirmed that even the 10mg dose effectively stimulates GH release and measurable IGF-1 elevation — making the 10mg tablet format an ideal starting point for first-cycle users and a proven effective maintenance dose for experienced researchers.

---

9 Researched Benefits of MK-677 (Ibutamoren) 10mg

1. Sustained GH & IGF-1 Elevation — The Core Clinical Finding

Strong evidence confirms: sustained, non-pulsatile elevation of serum IGF-1 and growth hormone following MK-677 administration. In a clinical study, the ibutamoren group showed IGF-1 increases of 84% versus 17% in the placebo group — a difference that reached statistical significance across multiple trial designs.

2. Lean Muscle Mass Growth

The best-studied trial in healthy older adults (25mg/day for 12 months) found fat-free mass increased by +1.1 kg versus placebo — confirming lean body mass accrual from sustained GH/IGF-1 elevation. MK-677 promotes muscle mass and nitrogen retention, activating the ghrelin receptor to drive anabolic signaling that is particularly effective in combination with structured resistance training.

3. Protection Against Diet-Induced Catabolism

Moderate-to-strong evidence: MK-677 prevents diet-induced nitrogen wasting (reversal of catabolism). This is one of its most practically valuable properties — during a caloric deficit, GH elevation protects lean tissue from being broken down for energy, ensuring the weight lost comes from fat rather than muscle. This makes MK-677 10mg for sale uniquely valuable during cutting cycles and GLP-1 weight loss protocols.

4. Deep Sleep Architecture Enhancement — Stage IV & REM Expansion

Strong clinical evidence: MK-677 produces a profound increase in Stage IV slow-wave sleep — the deepest, most restorative phase of sleep where GH is naturally secreted, tissue repair occurs, and memory consolidation happens. Clinical data demonstrates that MK-677 increases Stage IV deep sleep by up to 50% and REM sleep by up to 20% in both young and older adult research subjects.

This is the benefit users consistently report first — typically within the first 1–2 weeks of 10mg/day dosing. Deeper sleep. More vivid dreams. Waking more rested. And behind the scenes, more GH-driven overnight repair than your body has produced in years.

5. Bone Density & Bone Turnover Enhancement

Research shows that MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults, boosting bone mineral density parameters. A systematic review found ibutamoren stimulates bone turnover in the elderly based on elevations in biochemical markers of both bone resorption and formation. Long-term use (12+ months) demonstrated increase in bone mineral density — making MK-677 a compound of interest in osteoporosis and fracture recovery research.

6. Hip Fracture Recovery — Functional Improvement Data

A clinical study on ibutamoren in hip fracture recovery found improvement in stair climbing power and gait speed in the ibutamoren group. There was also a tendency towards more independent living in ibutamoren subjects — and in particular, 70% of patients who were independent before hip fracture (p=0.036) showed this trend. A smaller study (n=123) with a similar design confirmed the improvement in physical function outcomes.

7. Anti-Aging — GH Axis Restoration

GH and IGF-1 levels naturally decline with age — a process called somatopause that accelerates after 30. MK-677 may help restore hormonal profiles to more youthful levels, supporting better skin elasticity, hair quality, and general vitality. In clinical research, 25mg/day for 12 months successfully elevated GH and IGF-1 to concentrations equivalent to those found in healthy young adults

8. Enhanced Recovery — Tissue Repair & Injury Healing

Some users report faster healing of muscle strains, joint pain, and tendon issues — likely due to enhanced tissue regeneration from elevated GH and IGF-1. GH is directly involved in collagen synthesis, satellite cell activation, and connective tissue remodeling — all processes that accelerate recovery from training-induced damage and injury.

9. No Testosterone Suppression — PCT Not Required (Solo Use)

MK-677 demonstrates no significant affinity for androgen receptor pathways. It produces zero testosterone suppression when used alone — which means no PCT is required after a MK-677 solo cycle. This is one of its defining research advantages over SARMs and anabolic steroids, making it stackable at any stage — including during PCT itself — to preserve lean mass while natural testosterone recovers.

---

Research Benefits Summary Table

---

MK-677 (Ibutamoren) Dosage Guide — 10mg Tablets

The 10mg per tablet format is the most flexible format available — supporting every stage of the dosing ladder from cautious 10mg beginner protocols through standard 25mg advanced research doses.

Dosage for Men

MK-677 has been studied in published clinical trials using 10mg, 25mg, and 50mg daily doses — with 25mg being the most widely studied dose for GH/IGF-1 optimization. The research dosage sweet spot is clearly in the 10–25mg range. Clinical research confirmed that even 10mg/day effectively stimulates GH release.

25mg is considered the sweet spot. Even advanced users rarely go higher — effects start to diminish above 25mg while side effects (hunger, water retention) increase significantly. At that point, adding a complementary SARM to the stack produces far better results than further MK-677 dose escalation.

Dosage for Women

Women respond well to MK-677 given its non-androgenic mechanism. 5–10mg per day is an appropriate and effective female research dose — producing measurable GH/IGF-1 elevation, sleep improvement, and lean mass support without virilization risk.

How the 50-Tablet Pack Maps to Your Protocol

For a complete 12-week 10mg/day protocol: 2 packs provide 100 days — with buffer. For a 12-week 20mg/day protocol: 5 packs. Stock accordingly.

---

How to Use MK-677 (Ibutamoren) 10mg Tablets — Step-by-Step Protocol

Step 1 — Take Once Daily Before Bed
The best time to take MK-677 is before bed — typically 30–60 minutes before sleep. This timing aligns the compound’s GH-stimulating peak with the body’s natural nocturnal GH pulse during deep slow-wave sleep, amplifying both the hormonal effect and the sleep architecture improvement. The drowsiness many users feel after dosing is a sign the GH pulse has been triggered — lean into it.

Step 2 — Take With Food (Optional but Recommended)
MK-677 can significantly amplify appetite — particularly at doses of 20mg+. Taking it with a small, protein-rich evening meal helps buffer the hunger response and makes the appetite increase more manageable.

Step 3 — Titrate Up Gradually
Start at 10mg/day for the first 2 weeks to assess tolerance — particularly regarding appetite, water retention, and blood glucose response. Once comfortable, escalate to 20mg, then 25mg if desired. The 10mg starting dose is not a “starter dose only” — it’s a legitimately effective research dose with confirmed IGF-1 elevation in clinical studies.

Step 4 — Cycle Length & Timing
MK-677 cycles of 8–16 weeks are standard. Unlike SARMs, it does not suppress testosterone — so longer cycles (including 12–16 weeks or even extended continuous use) are more permissible from a hormonal standpoint. However, monitoring of fasting blood glucose and insulin sensitivity is strongly recommended on any cycle longer than 8 weeks, particularly at doses above 10mg/day.

Step 5 — Monitor Blood Glucose
MK-677’s 24-hour half-life creates continuous GH elevation — unlike natural pulsatile GH. Continuous GH elevation chronically antagonizes insulin, which can elevate fasting blood glucose and reduce insulin sensitivity at higher doses. Monitor fasting glucose at weeks 4 and 8. If glucose begins rising meaningfully, dose reduction or cycle break is the correct response.

Step 6 — No PCT Required (Solo Cycle)
MK-677 alone requires no post-cycle therapy — it does not affect the HPTA axis, testosterone production, or LH/FSH signaling. Simply stop dosing at cycle end and hormonal status remains unaffected. If stacked with suppressive SARMs, PCT is required for the SARM component — MK-677 can actually continue through PCT to help preserve lean mass during recovery.

---

Best Stacking Cycles With MK-677 (Ibutamoren) 10mg

MK-677 is uniquely versatile as a stack component — it doesn’t suppress testosterone, adds no androgenic load, and actively counteracts some of the most common SARM side effects (hair loss, poor sleep, reduced recovery). This makes it the perfect complement to virtually any research compound stack.

Lean Bulking Stack — The Classic

For bulking, an MK-677 + LGD-4033 + RAD-140 combination is highly recommended — helping increase muscle mass and strength while improving recovery time and reducing inflammation.

Cutting Stack — Muscle Preservation Priority

For cutting, MK-677 can be effectively stacked with Cardarine (GW-501516) or Stenabolic (SR9009) — MK-677 providing muscle preservation and GH-driven fat metabolism, while Cardarine or Stenabolic drive endurance and fat oxidation through entirely different receptor pathways.

Recomposition Stack — Simultaneous Fat Loss & Muscle Growth

PCT Support Stack — Preserve Gains While Recovering

MK-677 during PCT: 20–25mg/day alongside Nolvadex or Clomid for 4–6 weeks. MK-677 preserves lean mass during the testosterone recovery window — when catabolic hormone patterns can cause significant muscle loss — without interfering with the SERM’s LH/FSH restoration function.

Anti-Aging / Longevity Protocol

---

MK-677 (Ibutamoren) vs. Injectable GH Peptides — The Complete Comparison

The bottom line: MK-677 is the only compound in this table you can take orally, at stable daily dosing, with 24-hour GH axis coverage, zero injections, and human Phase II clinical data — at the best cost-per-milligram of any comparable GH axis compound on the market.

---

Possible Side Effects of MK-677 (Ibutamoren) 10mg

Full transparency is non-negotiable. MK-677’s side-effect profile is distinct from traditional steroids and SARMs — the risks are real but manageable, particularly at the 10mg research dose level.

Common Side Effects

Metabolic Risk — The Critical Monitoring Point

MK-677’s 24-hour half-life creates continuous rather than pulsatile GH elevation — unlike the body’s natural GH pattern. This constant elevation chronically antagonizes insulin, potentially elevating fasting blood glucose and worsening insulin sensitivity at doses of 20mg+ and with prolonged use. Average fasting glucose increased and insulin sensitivity worsened in the 12-month 25mg/day trial.

What MK-677 Does NOT Cause

⚠️ MK-677 (Ibutamoren) is not approved by the FDA for human consumption, therapeutic use, or diagnostic application. It is sold strictly for laboratory and research purposes only. Laws governing research chemicals vary by jurisdiction — verify compliance before purchasing. Always consult a licensed healthcare professional before any research protocol involving GH axis compounds.

---

FAQs About MK-677 (Ibutamoren) 10mg — 50 Tablets

1. What is MK-677 (Ibutamoren) and what does it do?

MK-677 (Ibutamoren) is a non-peptide, orally bioavailable agonist of the growth hormone secretagogue receptor (GHS-R1a). Originally developed by Merck & Co., it stimulates the pituitary gland to release growth hormone and raises IGF-1 levels through the ghrelin receptor pathway. It has been studied for GH deficiency, muscle wasting, osteoporosis, hip fracture recovery, and Alzheimer’s disease across multiple Phase II clinical trials.

---

2. Is MK-677 a SARM?

No — technically, MK-677 is not a SARM. SARMs are Selective Androgen Receptor Modulators that bind to the androgen receptor. MK-677 acts on the GHS-R1a (ghrelin receptor) — an entirely different receptor pathway. MK-677 is a growth hormone secretagogue with no androgen receptor affinity, which is why it causes no testosterone suppression and requires no PCT.

---

3. Does MK-677 (Ibutamoren) require PCT?

No — MK-677 used alone requires no post-cycle therapy. It does not suppress testosterone, LH, or FSH — its mechanism is entirely non-androgenic. When stacked with suppressive SARMs, PCT is required for the SARM component, but MK-677 can continue through PCT to help preserve lean mass during the recovery window.

---

4. What is the best dose of MK-677 10mg tablets for research?

10mg/day (1 tablet) is the clinically confirmed starting dose — proven to elevate IGF-1 and stimulate GH release in published trials. 25mg/day (2.5 tablets) is the most widely studied dose for GH/IGF-1 optimization and is considered the sweet spot for research — above 25mg, effects diminish while side effects increase meaningfully.

---

5. When is the best time to take MK-677 10mg tablets?

Before bed — approximately 30–60 minutes before sleep. This timing aligns MK-677’s GH pulse with the body’s natural nocturnal GH surge during deep slow-wave sleep, amplifying both the hormonal benefit and sleep quality improvement. The drowsiness that follows dosing is a positive sign — it signals the GH pulse has been activated.

---

6. How much does MK-677 increase GH and IGF-1?

In a double-blind randomized study of adults aged 60–81 taking 25mg/day, MK-677 increased 24-hour mean GH and IGF-1 toward young-adult levels. The ibutamoren group showed IGF-1 increases of 84% versus 17% in the placebo group — a statistically significant difference confirmed across multiple clinical trial designs.

---

7. Does MK-677 improve sleep quality?

Yes — this is one of its strongest and most consistent clinical findings. MK-677 produces a profound increase in Stage IV slow-wave sleep (deep sleep) of up to 50% and REM sleep of up to 20% in both young and older adults. Most users notice improved sleep quality within the first 1–2 weeks of 10mg/day dosing — making it one of the fastest-onset benefits of any GH-axis compound.

---

8. What are the main side effects of MK-677 at 10mg?

At the 10mg research dose, side effects are minimal for most subjects. MK-677 is well-tolerated at 10mg/day — with short-lived side effects including mild appetite increase, occasional transient water retention, and initial drowsiness post-dose. More significant side effects (pronounced hunger, edema, insulin resistance) are dose-dependent and primarily emerge at 20–25mg+ doses with prolonged use. Blood glucose monitoring is recommended for cycles longer than 8 weeks.

---

9. What stacks best with MK-677 (Ibutamoren) 10mg?

For bulking: MK-677 + LGD-4033 + RAD-140 (12 weeks). For cutting: MK-677 + MK-2866 (Ostarine) + Cardarine. For recomposition: MK-677 + Ostarine + RAD-140. MK-677 is also used during PCT after steroid or SARM cycles at 20–25mg/day to preserve lean mass while natural testosterone recovers — without interfering with SERM therapy.

---

10. Does MK-677 cause water retention?

Yes — particularly in the first week of use and at higher doses. Water retention is one of the most commonly reported side effects of MK-677 — especially in the first week of use. However, it typically stabilizes after the initial adjustment period. Sodium restriction, adequate hydration, and dose management (staying at 10–15mg/day) significantly reduce the severity of water retention for most users.

---

11. Can women use MK-677 (Ibutamoren) 10mg tablets?

Yes — MK-677 is non-androgenic and carries no virilization risk, making it well-suited for female research subjects. A dose of 5–10mg per day provides effective GH/IGF-1 elevation, sleep improvement, and lean mass support in women without any of the androgenic side-effect concerns associated with SARMs or anabolic steroids.

---

12. How long should an MK-677 research cycle last?

Standard research cycles run 8–16 weeks, with some extended protocols running 12 months or longer given MK-677’s non-suppressive hormonal profile. The key monitoring variable is blood glucose — extended cycles at 20mg+ doses require regular fasting glucose checks. A break equal to cycle length is a sensible approach; alternatively, lower 10mg maintenance doses can be sustained for longer periods with lower metabolic risk.